TRAF3 and B-cell non-Hodgkin lymphoma: To do so, we employed CRISPR/Cas9 technique to delete traf3 gene in Ly1 human B cell lymphoma and verified the absence of TRAF3 protein in the KO lymphoma clone (Ly1-57) (Supplementary Fig. 6).